中晚期肺癌患者癌症复发恐惧现状及其影响因素与护理启示 [中文引用][英文引用]

目的  探讨中晚期肺癌患者癌症复发恐惧（fear of cancer recurrence，FCR）的现状并分析其影响因素，为制定针对性干预方案提供参考依据。方法  采用方便抽样法，选取 2023 年 9 月至 2024 年 9 月就诊于本市某三级甲等肿瘤专科医院的 225 例中晚期肺癌患者为研究对象，采用一般资料调查表、恐惧疾病进展简化量表（fear of progression questionnaire shortform，FoP-Q-SF）、社会支持评定量表（social support rating scale，SSRS）、医学应对方式问卷（medical coping mode questionnaire，MCMQ）、Connor-Davidson 心理弹性量表（Connor-Davidson resilience scale，CD-RISC）对患者进行调查，运用多重线性回归分析中晚期肺癌患者 FCR 的影响因素。结果  199 例患者完成研究。中晚期肺癌患者 FCR 得分为（28.9±9.1）分，72 例（36.2%）患者存在病理性 FCR（总分≥ 34 分）。多重线性回归分析结果显示，社会支持水平越低、倾向回避和屈服应对方式、心理弹性水平越低的中晚期肺癌患者 FCR 水平越高（均 P<0.05），解释总变异的 42.7%。结论  中晚期肺癌患者 FCR 处于中等水平，医护人员应早期识别高风险患者，并制订针对性措施予以干预，以降低患者 FCR 水平。

Objective To describe the fear of cancer recurrence among the patients with middle and advanced lung cancer and explore the influencing factors for reference for making targeted interventions. Methods This study employed a cross-sectional design and convenience sampling approach to recruit 225 patients diagnosed with middle and advanced lung cancer between September 2023 and September 2024. Data were collected through a structured survey comprising a general information questionnaire，the fear of progression questionnaire-short form（FoP-Q-SF），social support rating scale（SSRS），medical coping modes questionnaire（MCMQ） and Connor-Davidson resilience scale（CD-RISC）. Multiple linear regression analysis was conducted to identify factors that influenced the fear of cancer recurrence among these patients. Results 199 patients finished the study. Among the 199 patients with middle and advanced lung cancer，the score was（28.9±9.1）72（36.2%）exhibited severe/pathological fear of cancer recurrence，defined as a total score of 34 or higher. The multiple linear regression modelling indicated that poor social support，a greater tendency toward avoidance and resignation coping mode，and reduced psychological resilience were significantly associated with higher levels of fear of cancer recurrence （all P<0.05），collectively accounting for 42.7% of the variance. Conclusion The fear of cancer recurrence among patients with middle and advanced lung cancer is at a moderate level. Healthcare professionals should identify high-risk individuals early and implement targeted interventions to effectively reduce the level of fear of cancer recurrence.